ZUG, Switzerland and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending and presenting at the following upcoming investor conferences: Stifel Biotech Executive Summit Format: Fireside chat Presenter: Riad Sherif, MD, Chief Executive OfficerPresentation date and time: February 7, 2024 at 7:30 am MT (Mountain Time)Lo
Boston
Massachusetts
United-states
Utah
France
Park-city
Amsterdam
Noord-holland
Netherlands
Switzerland
Sylvia-cheung
Corey-davis